...includes budesonide, glycopyrronium and formoterol fumarate, vs. the pharma's Bevespi Aerosphere glycopyrronium/formoterol fumarate and PT009 budesonide/formoterol...

...compound #), dapagliflozin (Generic), Forxiga (Other) Imfinzi, durvalumab (MEDI4736) Lynparza, olaparib (AZD2281, KU-0059436, MK-7339) Pulmicort, budesonide turbuhaler Symbicort, budesonide/formoterol (Symbicort Turbuhaler) Tagrisso...

...compound #), dapagliflozin (Generic), Forxiga (Other) Imfinzi, durvalumab (MEDI4736) Lynparza, olaparib (AZD2281, KU-0059436, MK-7339) Pulmicort, budesonide turbuhaler Symbicort, budesonide/formoterol (Symbicort Turbuhaler) Tagrisso...

...Highmark Inc. affiliate and AstraZeneca plc (LSE:AZN; NYSE:AZN) entered into an outcomes-based contract for Symbicort budesonide/formoterol...
...the agreement is the company's first outcomes-based contract for a respiratory therapy. Highmark will evaluate Symbicort...
...Cross and Blue Shield Association, Chicago, Ill. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Pulmonary Sandi Wong Symbicort AstraZeneca...

...Highmark Inc. affiliate and AstraZeneca plc (LSE:AZN; NYSE:AZN) entered into an outcomes-based contract for Symbicort budesonide/formoterol...
...the agreement is the company's first outcomes-based contract for a respiratory therapy. Highmark will evaluate Symbicort...
...that if a positive outcome is not achieved, the company "will realize a financial savings." Sandi Wong Symbicort AstraZeneca...

...which will have a small, if any, positive impact on future sales. Older respiratory drugs Symbicort...

...primary endpoints evaluated post-dose forced expiratory volume in one second (FEV1) for PT010 vs. Symbicort budesonide/formoterol...
...from baseline in post-dose forced expiratory volume in one second (FEV1) for PT010 vs. Symbicort budesonide/formoterol...
...application (2H18); submit NDA (2019); submit MAA (2019); Phase III data (2019) Jaime De Leon Bevespi Aerosphere budesonide/formoterol glycopyrronium/formoterol fumarate PT003 PT010 Symbicort AstraZeneca...

...points in patients treated with PT010 vs. patients treated twice daily with AZ products Symbicort budesonide/formoterol...
...trough FEV1 at 24 weeks. Two additional endpoints were met evaluating non-inferiority of PT009 to Symbicort...
...an HFA metered-dose inhaler, is approved as long-term maintenance treatment for COPD. Jaime De Leon Bevespi Aerosphere budesonide/formoterol glycopyrronium/formoterol fumarate PT003 PT010 Symbicort AstraZeneca...

...In September, FDA approved Symbicort budesonide/formoterol from AstraZeneca plc (LSE:AZN; NYSE:AZN) to reduce exacerbations of chronic...
...in patients ages ≥6. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Product: Symbicort budesonide/formoterol Business: Pulmonary Meghan Sullivan budesonide/formoterol Symbicort AstraZeneca...

...Ellipta for maintenance treatment of COPD. Innoviva was off $0.30 to $13.51 on Tuesday. Jennie Walters budesonide/formoterol fluticasone furoate/umeclidinium/vilanterol Symbicort Turbuhaler AstraZeneca...